FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2135222796> ?p ?o ?g. }

• W2135222796 endingPage "720" @default.
• W2135222796 startingPage "713" @default.
• W2135222796 abstract "Therapy of chronic hepatitis delta with standard interferon therapy has met with limited efficacy. This study was designed to examine the efficacy and safety of peginterferon with or without ribavirin. Thirty-eight serum hepatitis B surface antigen- and HDV RNA-positive patients with alanine aminotransferase (ALT) more than 1.5 times the upper normal limit received peginterferon alpha-2b (1.5 microg/kg) alone as monotherapy (n=16) or in combination with ribavirin (n=22), for 48 weeks. Thereafter, all the patients were maintained on peginterferon for 24 weeks and followed for 24 weeks off therapy. The primary end point studied was the virological and biochemical response at the end of follow-up. HDV RNA was determined by single or nested polymerase chain reaction assays. Twenty-seven patients (71%), 11 receiving monotherapy and 16 receiving the combination treatment, completed the follow-up. At the end of treatment, a virological response was observed in 3 of the patients treated with peginterferon (19%) and in 2 of the patients treated with combination therapy (9%), and a biochemical response was observed in 6 (37.5%) and 9 patients (41%), respectively. In nonresponders, ALT diminished from a mean of 174+/-53 to 86+/-41 IU/L. At the end of follow-up, serum HDV RNA was negative in 8 patients (21%), and a biochemical response was detected in 10 patients (26%). Treatment was discontinued in 25% of the patients, and dosing was modified in 58%. In conclusion, a prolonged course of peginterferon alpha-2b resulted in clearance of serum HDV RNA and ALT normalization in a fifth of patients with chronic hepatitis D, while ribavirin had no effect on the viral clearance rate. Overall tolerance of therapy was poor." @default.
• W2135222796 created "2016-06-24" @default.
• W2135222796 creator A5004667227 @default.
• W2135222796 creator A5015267957 @default.
• W2135222796 creator A5016122300 @default.
• W2135222796 creator A5017099838 @default.
• W2135222796 creator A5021141713 @default.
• W2135222796 creator A5027673519 @default.
• W2135222796 creator A5058540507 @default.
• W2135222796 creator A5067281862 @default.
• W2135222796 creator A5068912252 @default.
• W2135222796 creator A5073395217 @default.
• W2135222796 creator A5079659653 @default.
• W2135222796 creator A5081041335 @default.
• W2135222796 creator A5091031530 @default.
• W2135222796 date "2006-01-01" @default.
• W2135222796 modified "2023-10-11" @default.
• W2135222796 title "Pegylated interferon alpha-2b as monotherapy or in combination with ribavirin in chronic hepatitis delta" @default.
• W2135222796 cites W1974511288 @default.
• W2135222796 cites W1989671349 @default.
• W2135222796 cites W1997575584 @default.
• W2135222796 cites W1999110170 @default.
• W2135222796 cites W2003491234 @default.
• W2135222796 cites W2003677093 @default.
• W2135222796 cites W2011934019 @default.
• W2135222796 cites W2011951516 @default.
• W2135222796 cites W2020963980 @default.
• W2135222796 cites W2028348627 @default.
• W2135222796 cites W2040656569 @default.
• W2135222796 cites W2047446677 @default.
• W2135222796 cites W2059239478 @default.
• W2135222796 cites W2081626151 @default.
• W2135222796 cites W2083785084 @default.
• W2135222796 cites W2085268000 @default.
• W2135222796 cites W2087351301 @default.
• W2135222796 cites W2106762291 @default.
• W2135222796 cites W2137468460 @default.
• W2135222796 cites W2144259811 @default.
• W2135222796 cites W2149782865 @default.
• W2135222796 cites W2329648617 @default.
• W2135222796 cites W2411800125 @default.
• W2135222796 doi "https://doi.org/10.1002/hep.21296" @default.
• W2135222796 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/16941685" @default.
• W2135222796 hasPublicationYear "2006" @default.
• W2135222796 type Work @default.
• W2135222796 sameAs 2135222796 @default.
• W2135222796 citedByCount "208" @default.
• W2135222796 countsByYear W21352227962012 @default.
• W2135222796 countsByYear W21352227962013 @default.
• W2135222796 countsByYear W21352227962014 @default.
• W2135222796 countsByYear W21352227962015 @default.
• W2135222796 countsByYear W21352227962016 @default.
• W2135222796 countsByYear W21352227962017 @default.
• W2135222796 countsByYear W21352227962018 @default.
• W2135222796 countsByYear W21352227962019 @default.
• W2135222796 countsByYear W21352227962020 @default.
• W2135222796 countsByYear W21352227962021 @default.
• W2135222796 countsByYear W21352227962022 @default.
• W2135222796 countsByYear W21352227962023 @default.
• W2135222796 crossrefType "journal-article" @default.
• W2135222796 hasAuthorship W2135222796A5004667227 @default.
• W2135222796 hasAuthorship W2135222796A5015267957 @default.
• W2135222796 hasAuthorship W2135222796A5016122300 @default.
• W2135222796 hasAuthorship W2135222796A5017099838 @default.
• W2135222796 hasAuthorship W2135222796A5021141713 @default.
• W2135222796 hasAuthorship W2135222796A5027673519 @default.
• W2135222796 hasAuthorship W2135222796A5058540507 @default.
• W2135222796 hasAuthorship W2135222796A5067281862 @default.
• W2135222796 hasAuthorship W2135222796A5068912252 @default.
• W2135222796 hasAuthorship W2135222796A5073395217 @default.
• W2135222796 hasAuthorship W2135222796A5079659653 @default.
• W2135222796 hasAuthorship W2135222796A5081041335 @default.
• W2135222796 hasAuthorship W2135222796A5091031530 @default.
• W2135222796 hasConcept C126322002 @default.
• W2135222796 hasConcept C203014093 @default.
• W2135222796 hasConcept C2522874641 @default.
• W2135222796 hasConcept C2776178377 @default.
• W2135222796 hasConcept C2776461080 @default.
• W2135222796 hasConcept C2776699657 @default.
• W2135222796 hasConcept C2776999253 @default.
• W2135222796 hasConcept C2777288759 @default.
• W2135222796 hasConcept C2777410769 @default.
• W2135222796 hasConcept C2778606649 @default.
• W2135222796 hasConcept C2780040827 @default.
• W2135222796 hasConcept C2780593183 @default.
• W2135222796 hasConcept C2909179924 @default.
• W2135222796 hasConcept C2992872382 @default.
• W2135222796 hasConcept C3020491458 @default.
• W2135222796 hasConcept C71924100 @default.
• W2135222796 hasConcept C90924648 @default.
• W2135222796 hasConceptScore W2135222796C126322002 @default.
• W2135222796 hasConceptScore W2135222796C203014093 @default.
• W2135222796 hasConceptScore W2135222796C2522874641 @default.
• W2135222796 hasConceptScore W2135222796C2776178377 @default.
• W2135222796 hasConceptScore W2135222796C2776461080 @default.
• W2135222796 hasConceptScore W2135222796C2776699657 @default.
• W2135222796 hasConceptScore W2135222796C2776999253 @default.
• W2135222796 hasConceptScore W2135222796C2777288759 @default.

• next